Product Code: ANV952
REPORT HIGHLIGHT
The Superdisintegrants Market size was valued at USD 490.7 Million in 2021, expanding at a CAGR of 7.2% from 2022 to 2028.
Superdisintegrants are one of the various excipient types utilized in the pharmaceutical industry for tablet-based medication administration. To assist them to dissolve when submerged in a liquid, superdisintegrants are added to solid dosage forms like pills or tablets. The tablet's increased surface area from breaking into smaller pieces speeds up medication release.
Market Dynamics:
The development of unique superdisintegrant mixtures is a significant advancement in the pharmaceutical sector. With the help of these preparations, manufacturers now have access to a wide range of superdisintegrants, such as co-processed excipients, which are made up of several synthetic superdisintegrants, natural and synthetic superdisintegrants, or synthetic superdisintegrants combined with other pharmaceutical excipients. The active components' fast action, helps to improve the way medications work. Disintegrants are specifically developed for use in the direct compression method of tablet formulations, which eliminates several wet and dry granulation-related processing steps. One of the fastest-growing drug delivery methods using superdisintegrants for direct compression is oral disintegrating tablets (ODTs). A favorable regulatory environment in the developed regions is also progressively supporting growth in the acceptance of innovative excipients. The creation and application of novel excipients have been supported by the International Pharmaceutical Excipients Council (IPEC). To reduce the expense and uncertainty associated with the use of innovative excipients in pharmaceutical formulations, the council has established a novel excipient review approach as an independent process. Therefore, the emergence of new superdisintegrants in the pharmaceutical industry is expected to drive market growth during the forecast period.
However, despite the expanding usage of excipients in medicines, the market for superdisintegrants still has a difficult time meeting up to the high standards set by regulators, consumers, drug manufacturers, and-most importantly-patients. Superdisintegrant production variations have an impact on both the important quality characteristics and the efficacy of drugs. Superdisintegrant concentration fluctuations from supplier to supplier or batch to batch have an impact on the interaction between excipients and drugs, which in turn has an impact on drug efficacy and quality.
COVID-19 Analysis:
The ongoing COVID-19 pandemic had a big effect on the bioanalytical and pharmaceutical industries, especially in the areas of therapeutic research and backing for ongoing drug trials. The dynamics of the industry were somewhat influenced by the difficulties faced by various existing procedures in managing the reduction in manpower at sites and the increased workloads for other COVID-19-related support. However, shortly, the business might slowly come back into existence due to increasing awareness of the higher risk of coronavirus infection among neurological patients. It has been demonstrated that in some patients, an overreactive reaction to the virus raises the risk of dementia, stroke, vascular diseases, and encephalitis. Orally disintegrating tablets are frequently employed as a therapy option for patients with neurological problems like these, therefore drug production is projected to experience a considerable increase, which will ultimately lead to good growth for the industry as a whole.
Geography: Segment Analysis
With the largest revenue share in the superdisintegrants market in 2021, North America dominated the market. A few significant market drivers are the rise in demand for generic medications, improved innovation in the production of superdisintegrants, and manufacturing methods. Additionally, some of the most prominent players in the market for superdisintegrants are based in North America.
However, during the projected period, Asia Pacific is anticipated to develop at the fastest rate. Growth in the Asia Pacific region is anticipated to be fueled by aspects such as rising outsourcing of excipients, including superdisintegrants, production of new superdisintegrants, and adoption of novel technologies (New drug delivery system).
Recent Development:
In March 2021, Formulationbio announced the Launch of Disintegrant Excipients for Pharmaceutical Preparation.
Key features of the study:
This proposed research study on the Superdisintegrants market provides market size (US$ Million), compound annual growth rate (CAGR %) and forecast estimation (2022-2028), considering 2021 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains an attractive investment proposition matrix for the Superdisintegrants market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain the Superdisintegrants market
The impact of COVID-19 on the Superdisintegrants market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight into the Superdisintegrants market post-COVID will also be covered.
To give the users of this report a comprehensive view of the Superdisintegrants market, we have also included a competitive landscape and key innovator analysis for the Superdisintegrants market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand the financial information and strategic initiatives of players operating in the Superdisintegrants market.
In addition, the report also unveils the important acquisitions & mergers, collaborations & joint ventures, new launches, research & development, and regional expansion of major participants involved in the market on global as well as regional levels.
The global Superdisintegrants market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL SUPERDISINTEGRANTS MARKET KEY PLAYERS
BASF SE
DuPont
Ashland Global Holdings Inc.
Roquette Freres
DFE Pharma
JRS PHARMA
Asahi Kasei Corporation
Merck KGaA
Corel Pharma Chem
Avantor Performance Materials
NIPPO SODA CO., LTD.
Sigachi Industries
Colorcon
NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD.
GLOBAL SUPERDISINTEGRANTS MARKET, BY TYPE
Natural Superdisintegrants
Synthetic Superdisintegrants
Others
GLOBAL SUPERDISINTEGRANTS MARKET, BY FORMULATION
Tablets
Capsules
GLOBAL SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA
Gastrointestinal Diseases
Neurological Diseases
Oncology
Infectious Diseases
Cardiovascular Diseases
Hematological Diseases
Inflammatory Diseases
GLOBAL SUPERDISINTEGRANTS MARKET, BY REGION
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA
TABLE OF CONTENT
1. Superdisintegrants Market Overview
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Market Snippet by Type
- 2.1.2. Market Snippet by Formulation
- 2.1.3. Market Snippet by Therapeutic Area
- 2.1.4. Market Snippet by Region
- 2.2. Competitive Insights
3. Superdisintegrants Key Market Trends
- 3.1. Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Future Trends
4. Superdisintegrants Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Superdisintegrants Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Superdisintegrants Market Landscape
- 6.1. Market Share Analysis, 2021
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Superdisintegrants Market - By Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2021 & 2028 (%)
- 7.1.2. Natural Superdisintegrants
- 7.1.3. Synthetic Superdisintegrants
- 7.1.4. Others
8. Superdisintegrants Market - By Formulation
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Formulation, 2021 & 2028 (%)
- 8.1.2. Tablets
- 8.1.3. Capsules
9. Superdisintegrants Market - By Therapeutic Area
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Therapeutic Area, 2021 & 2028 (%)
- 9.1.2. Gastrointestinal Diseases
- 9.1.3. Neurological Diseases
- 9.1.4. Oncology
- 9.1.5. Infectious Diseases
- 9.1.6. Cardiovascular Diseases
- 9.1.7. Hematological Diseases
- 9.1.8. Inflammatory Diseases
10. Superdisintegrants Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2021 & 2028 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
11. Key Vendor Analysis
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. BASF SE
- 11.2.2. DuPont
- 11.2.3. Ashland Global Holdings Inc.
- 11.2.4. Roquette Freres
- 11.2.5. DFE Pharma
- 11.2.6. JRS PHARMA
- 11.2.7. Asahi Kasei Corporation
- 11.2.8. Merck KGaA
- 11.2.9. Corel Pharma Chem
- 11.2.10. Avantor Performance Materials
- 11.2.11. NIPPO SODA CO., LTD.
- 11.2.12. Sigachi Industries
- 11.2.13. Colorcon
- 11.2.14. NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD.
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us